Evolution of adherence to antiretroviral treatment in a spanish hospital during 2001, 2005 and 2008 by Echarri Martínez, Lara et al.
1173ISSN 0326-2383
KEY WORDS: Adherence antiretroviral therapy, HAART, Predictive factors.
* Author to whom correspondence should be addressed. E-mail: lecharri.hgugm@salud.madrid.org
Latin American Journal of Pharmacy
(formerly Acta Farmacéutica Bonaerense)
Lat. Am. J. Pharm. 30 (6): 1173-8 (2011)
Regular Article
Received: September 17, 2010
Revised version: February 24, 2011
Accepted: March 2, 2011
Evolution of Adherence to Antiretroviral Treatment
in a Spanish Hospital During 2001, 2005 and 2008
Lara ECHARRI MARTÍNEZ 1*, Carmen G. RODRÍGUEZ GONZÁLEZ 1,
Isabel CASTILLO ROMERA 1, Alejandro N. TROVATO LÓPEZ 1, Arantza AIS LARISGOITIA 1,
José M. BELLÓN CANO 2 & María SANJURJO SÁEZ 1
1 Pharmacy Department, 2 Biomedical Research Foundation,
Hospital General Universitario Gregorio Marañón, c/Doctor Esquerdo, 46 28007 Madrid, Spain.
SUMMARY. The aim of this study was to analyze the evolution of adherence to highly active antiretrovi-
ral therapy (HAART) in the Hospital General Universitario Gregorio Marañón (Madrid, Spain) over the
last 8 years and determine the variables associated with the complexity of treatment and suboptimal ad-
herence. An observational, retrospective method was used to measure adherence during the first 6 months
of HAART in 3 cohorts: 2001 cohort (n = 90), 2005 cohort (n = 98), and 2008 cohort (n = 110). The adher-
ence rate was determined using 2 methods: Pharmacy Department dispensation records and virologic re-
sponse data. The evolution of the complexity of treatment and its influence on the adherence rate was ana-
lyzed by logistic regression. Adherence to HAART increased progressively from 45.6 % in 2001 to 56.1 %
in 2005 and 77.3 % in 2008. Statistically significant differences were only observed between cohorts in
2005 and 2008. The average daily pill burden was 7, 4, and 4.5 tablets, respectively. The percentage of pa-
tients on twice-daily regimens decreased from 93.3 % in 2001 to 63.6 % in 2008, with a parallel increase in
once-daily regimens. The proportion of patients with dietary restrictions decreased from 24.4 % to 3.6 %.
A statistically significant association was found between the number of medication units per day and ad-
herence and between frequency of administration and adherence. Adherence to HAART has improved
significantly in the last 8 years. While the complexity of the treatment was significantly reduced in 2005,
the largest increase in adherence occurred in the last cohort, which shows the influence of factors other
than treatment simplification.
